Cardiovascular Disease, Diabetes, and Diabetes Treatments: Understanding the Interrelationships
Live online March 1, 2017, (Sessions 1 and 2), and March 29, 2017 (Session 3), and available on demand through September 29 2017.
Posted by...Bernard Sklar, MD.
Free Cardiovascular and Diabetes CME Credit hours...3.0.
CME Credits Awarded by....University of Cincinnati.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for primary care clinicians, diabetes specialists, cardiologists, as well as other health care providers who provide front-line glycemic management for type 2 diabetes (T2DM) and its comorbidities.
Educational material updated...March 29, 2017.
Expiration of CME credit...September 29 2017.
Financial Support...Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC, and Novo Nordisk Inc.
This activity consists of three sessions, each of which should take approximately 1 hour to complete.
At the conclusion of Cardiovascular Disease, Diabetes, and Diabetes Treatments
, you will be able to:
• Discuss the etiologic and pathophysiologic interconnections among the components of the cardiometabolic syndrome and the development of cardiovascular disease
• Identify pharmacological actions of antidiabetes medications that could potentially impact cardiovascular outcomes
• Describe the rationale for studying the cardiovascular impact of antidiabetes medications
• Compare and contrast antidiabetes pharmacotherapies which can optimize glycemic control and minimize adverse effects on cardiovascular risk and/or disease
• Discuss the efficacy and safety data for recent trials that examined the cardiovascular impact of antidiabetes medications
• Delineate critical assessments of recent cardiovascular outcomes trials for antidiabetes medications with regard to their evidence-based clinical implications